GLPG2534

• CAT Number: I041173
• CAS Number: 2095615-97-5
• Molecular Formula: C21H24N6O4
• Molecular Weight: 424.45
• Purity: ≥95%
• Synonyms: 6-[6-[2-(2-hydroxyethoxy)ethoxy]-5-(oxan-4-ylamino)imidazo[4,5-b]pyridin-3-yl]pyridine-3-carbonitrile
• InChI: InChI=1S/C21H24N6O4/c22-12-15-1-2-19(23-13-15)27-14-24-17-11-18(31-10-9-30-8-5-28)20(26-21(17)27)25-16-3-6-29-7-4-16/h1-2,11,13-14,16,28H,3-10H2,(H,25,26)
• InChIKey: VNAPWQDUDZCVCA-UHFFFAOYSA-N
• SMILES: C1COCCC1NC2=C(C=C3C(=N2)N(C=N3)C4=NC=C(C=C4)C#N)OCCOCCO

GLPG2534（Cat No.:I041173）is a selective oral small molecule inhibitor currently under development for the treatment of autoimmune diseases. It targets and inhibits specific enzymes involved in the immune response, with the goal of reducing inflammation and modulating the immune system. GLPG2534 has shown promise in preclinical studies for treating conditions like rheumatoid arthritis and other inflammatory diseases. Clinical trials are underway to assess its safety, efficacy, and potential to provide a more targeted treatment option compared to traditional immunosuppressive therapies, with fewer side effects.